The MM-II trial was carried out in partnership with Israel-based Moebius Medical and included 397 patients in the US, Europe, ...

If you’re experiencing knee pain, it’s a good idea to look beyond the knees to identify the source of pain and address it, ...

New Delhi: A common diabetes drug can help reduce pain in people with knee osteoarthritis (OA) and obesity, as well as delay ...

A new study has uncovered another benefit of one of the country's most commonly prescribed medications for diabetes - joint ...

A new study has uncovered another benefit of one of the country's most commonly prescribed medications for diabetes - joint pain relief. A man on the Gold Coast has blamed the council for a water leak ...

A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying ...

A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying the need for knee replacements, Monash University-led research has found.

India's Sun Pharma and Israel's Moebius Medical published new data on MM-II, a non-opioid treatment for knee osteoarthritis.

The implant is designed to address cartilage defects in the knee that cause persistent pain, according to a press release from the company.

Adolore BioTherapeutics (”Adolore” or the “Company”) is developing intracellularly-delivered neuromodulators that naturally reduce neuronal excitability to restore balance to the PNS/CNS to treat the ...

Former Olympic athlete Allison Curbishley used to compete for Britain in the 400m, but by last year she was struggling to ...

Immy had just started driving lessons in January 2022, aged 17, when she began getting “shooting pains” in her left knee and thigh.